Reporting in Science, researchers write that an FDA-approved drug for skin cancer had surprising results in mice with Alzheimer’s. The drug rapidly cleared up amyloid protein from the brain and improved cognitive function. Co-author Gary Landreth discusses the drug’s potential as a therapy for Alzheimer’s.
Segment Guests
Gary Landreth
Gary Landreth is a Professor of Neurosciences and Director of the Alzheimer Research Laboratory at Case Western Reserve University. He’s based in Cleveland, Ohio.